Monavvar Andarva
I am currently a third-year PhD candidate in the School of Medicine, where my research focuses on novel therapeutic strategies for Secreted Phospholipase A2 type IIA enzyme (hGIIA) dependent diseases, including prostate cancer. My thesis project is conducted in collaboration with Filamon Ltd, a biotechnology start-up, and is partially supported by the NSW Government Office of Health and Medical Research Partnership Scholarship program.
Abstracts this author is presenting: